Describe the main elements of peptic ulcer disease and gastroesophageal reflux disease. Discuss antacids in terms of the prototype, indications and contraindications for use, routes of administration, and major adverse…
State the rationale for the increasing use of single daily doses of aminoglycosides. Discuss the importance of measuring serum drug levels during aminoglycoside therapy. Describe measures to decrease nephrotoxicity and…
Identify the common causes of diarrhea. Identify patients at risk for development of diarrhea. Describe opioid-related antidiarrheal agents in terms of the prototype, indications and contraindications for use, routes of…
Describe the etiology, pathophysiology, and clinical manifestations of substance abuse. Identify the central nervous system (CNS) depressants of abuse. Identify the prototypes and describe the action, use, adverse effects, contraindications,…
Define local anesthesia. Describe three types of local anesthesia. Identify the prototype and describe the action, use, adverse effects, contraindications, and nursing implications for the amide local anesthetics. Identify the…
Identify the common etiologies of inflammation. Discuss the pathophysiology of inflammation. Describe, in general, the groups of drugs used to treat inflammation. Identify the common pathogens and methods of infection…
Discuss cellular physiology in relation to drug therapy. Describe the main pathways and mechanisms by which drugs cross biologic membranes and move through the body. Explain each process of pharmacokinetics….
Define a prototype drug. Distinguish between generic and trade names of drugs. Describe the main categories of controlled substances in relation to therapeutic use, potential for abuse, and regulatory requirements….
Understand pharmacodynamics and pharmacokinetic changes related to age in older adults. Understand the relevance of the Beers Criteria to medication administration in the aging population. Identify the physiological changes associated…
Identify the characteristics of pediatric pharmacotherapy in children from birth to 18 years of age. Describe the evolution of pediatric pharmacotherapy and the purpose of federal legislation in the development…
